Ingmar L. Defize
Papers
4
Total Citations
58
H-Index
3
About
Ingmar L. Defize is a leading surgical oncologist whose research centers on advancing minimally invasive techniques for esophageal cancer, particularly through robot-assisted approaches. His most impactful work addresses the formidable challenge of treating cT4b esophageal cancer—tumors invading adjacent structures typically deemed inoperable. Defize’s landmark study on salvage Robot-Assisted Minimally Invasive Esophagectomy (RAMIE) after definitive chemoradiotherapy (30 citations) demonstrates that downstaging via chemoradiation can enable radical resection, offering a potential survival benefit to patients otherwise excluded from surgery. He also investigates the role of thoracic duct lymph node metastasis in Western patients (14 citations), providing critical data to refine lymphadenectomy protocols. Defize’s contributions extend to pioneering the surgical anatomy of transcervical esophagectomy (11 citations), a technique that avoids thoracic cavity entry and single-lung ventilation. His work has garnered international recognition, with his studies cited in major surgical guidelines. By pushing the boundaries of what is surgically possible, Defize is reshaping the landscape of esophageal cancer treatment, offering new hope for patients with advanced disease and setting a benchmark for future innovation in robotic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4